Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In people with obesity or overweight and with type 2 diabetes, MariTide demonstrated up to an approximately 17 percent average weight loss at 52 weeks, also without evidence of a weight loss plateau, which Amgen said indicates scope for further weight loss beyond 52 weeks
A recent study found that for seniors, a daily dose of 500 micrograms was efficient in reversing the signs of B12 deficiency
In Q1 2026, Amgen announced a SWITCH study enrolling 300 patients transitioning from weekly semaglutide or tirzepatide to MariTide on less frequent schedules, positioning the drug as a potential maintenance or step-down therapy
Caution should be exercised in patients with a history of pancreatitis
Our team will review these with you during your consultation to ensure youre fully informed
While Semaglutide helps manage blood sugar, it could also potentially trigger these stress responses in some individuals
US$ 19.99
US$ 29.16
US$ 20.16
US$ 25.96
